Implantable continuous glucose monitor device
AssigneeUXN Co., Ltd.
InventorsSejin Park, Sun Kil Kang
Life of this patent
Estimating the term…
Loading patent…
AssigneeUXN Co., Ltd.
InventorsSejin Park, Sun Kil Kang
Estimating the term…
A continuous glucose monitor (CGM) sensor includes a glucose oxidation electrode and a counter electrode, and does not include a glucose-specific enzyme. The glucose oxidation electrode includes a nanoporous layer comprising metal nanoparticles. The CGM sensor generates an electrical signal indicative glucose oxidation in a liquid containing glucose, which has a correlation with an effective surface area of the metal nanoparticles in the nanoporous layer. When the CGM sensor is implanted in a subject's body, an AC voltage is applied between the glucose oxidation electrode and the counter electrode, and impedance is obtained. A glucose level for the subject is determined using the impedance without use of information or data related to glucose sensitivity of a sensor or sensors over use or time.
A continuous glucose monitor (CGM) system comprising:
Dependencies are inferred from the claim text.